Chlamydia trachomatis: The role of cellular and humoral immune mechanisms in the development of blindness

Current Opinion in Infectious Diseases

Volumn 12, Issue 3, 1999, Pages 229-233

  Ghaem Maghami, Sadaf ^a   Lewis, David J M ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL VACCINE; CYTOKINE; NITRIC OXIDE;

BACTERIAL COLONIZATION; BLINDNESS; CELLULAR IMMUNITY; CHLAMYDIA TRACHOMATIS; EYE INFECTION; HELPER CELL; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; REVIEW; SANITATION; TRACHOMA;

EID: 0032817654     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001432-199906000-00012     Document Type: Review

References (41)

1. 1 Schachter J, Dawson CR. The epidemiology of trachoma predicts more blindness in the future. Scand J Infect Dis 1990; 69 (Suppl.):55-62.
2. 2 Zhang Y-X, Stewart S, Joseph T, Taylor H, Caldwell H. Protective monoclonal antibodies recognise epitopes located on the major outer membrane protein of Chlamydia trachomatis. J Immunol 1987; 138:575-581.
3. 3 Arno J, Xie C, Jones R, Van Der Pol B. Identification of T cells that respond to serovar-specific regions of the Chlamydia trachomatis major outer membrane protein in persons with serovar E infection. J Infect Dis 1998; 178:1713-1718.
4. 4 Morrison RP. Chlamydial hsp60 and the immunopathogenesis of chlamydial disease. Semin Immunol 1991; 3:25-33.
5. 5 Ward ME. The immunobiology and immunopathology of chlamydial infections. APMIS 1995; 103:769-796.
6. 6 Gerard H, Kohler I, Branigan P, Zeidler H, Schumacher H, Hudson A. Viability and gene expression in Chlamydia trachomatis during persistent infection of cultured monocytes. Med Microbiol Immunol (Berl) 1998; 187:115-120.
7. 7 Raulston J, Paul T, Knight S, Wyrick P. Localization of Chlamydia trachomatis heat shock proteins 60 and 70 during infection of a human endometrial epithelial cell line in vitro. Infect Immun 1998; 66:2323-2329.
8. 8 Ault K, Statland B, King M, Dozier D, Joachims M, Gunter J. Antibodies to the chlamydial 60 kilodalton heat shock protein in women with tubal factor infertility. Infect Dis Obstet Gynaecol 1998; 6:163-167.
9. 9 Peeling R, Bailey R, Conway D, Holland M, Campbell A, Jallow O, et al. Antibody response to the 60-KDa chlamydial heat-shock protein is associated with scarring trachoma. J Infect Dis 1998; 177:256-259. An important study of human humoral responses to hsp60 of C. trachomatist, showing for the first time an association between host antibody responses to hsp60 and trachomatous scarring. Subjects with trachomatous scarring had higher titers and a higher prevalence of antibodies against hsp60 compared with controls, who were subjects without clinical evidence of disease. This study also looks at the important relationship between genetic make up and immune response against hsp60.
10. 10 Mygind P, Christiansen G, Pesson K, Birkelund S. Analysis of the humoral immune response to the Chlamydia outer membrane protein 2. Clin Diagnost Lab Immunol 1998; 5:313-318.
11. 11 Bannantine J, Stamm W, Suchland R, Rockey D. Chlamydia trachomatis Inc A is localised to the inclusion membrane and is recognised by antisera from infected humans and primates. Infect Immun 1998; 66:6017-6021.
12. 12 Comanducci M, Manetti R, Bini L, Santucci A, Pallini V, Cevenini R, et al. Humoral immune response to plasmid protein pgp3 in patients with Chlamydia trachomatis infection. Infect Immun 1994; 62:5491-5497.
13. 13 Conway D, Holland M, Bailey R, Campbell A, Mahdi O, Jennings R, et al. Scarring trachoma is associated with polymorphism in the tumour necrosis factor alpha (TNF-α) gene promoter and with elevated TNF-α levels in tear fluid. Infect Immun 1997; 65:1003-1006.
14. 14 Nettlenbreker EZH, Bartels H, Dreses-Werrigloer U, Daubener W, Holtmann H, Kohler L. Studies of persistent infection by Chlamydia trachomatis serovar K in TPA-differentiated U937 cells and the role of IFN-gamma. J Med Microbiol 1998; 47:141-149. This cell culture study has explored effect of IFN-γ on the growth of Chlamydia in human macrophages and has shown that infection of U937 cells was not affected by IFN-γ. There was also IFN-γ-independent persistence of atypical chlamydiae in these cells with the expression of MOMP, hsp60 and lipopolysaccharide.
15. 15 Gerard H, Branigan P, Balsara G, Heath C, Minassian S, Hudson A. Viability of Chlamydia trachomatis in fallopian tubes of patients with ectopic pregnancy. Fertil Steril 1998; 70:945-948. An important study of human fallopian tissue for evidence of persistent chlamydial infection. This study has looked at the presence of chlamydial DNA and RNA species in human fallopian tube biopsy samples from women with ectopic pregnancies. Seven out of the 10 specimens examined were polymerase chain reaction-positive for chlamydial DNA.
16. 16 Dieterle S, Rummel C, Bader L, Peterson H, Fenner T. Presence of the major outer membrane protein of Chlamydia trachomatis in patients with chronic salpingitis and salpingitis isthmica nodosa with tubal occlusion. Fertil Steril 1998; 70:774-776.
17. 17 Bobo L, Novak N, Mkocha H, Vitale S, West S, Quinn TC. Evidence for a predominant proinflammatory conjunctival cytokine response in individuals with trachoma. Infect Immun 1996; 64:3273-3279.
18. 18 Abu-el-Asar A, Geboes K, Tabbara K, al-Kharashi S, Missotten L, Desmet V. Immunopathogenesis of conjunctival scarring in trachoma. Eye 1998; 12:453-460. An invaluable human study of conjunctival biopsies from subjects with trachoma and controls. The inflammatory cytokines and inflammatory cells were shown to be associated with trachoma. B lymphocytes were predominant compared with T lymphocytes in subjects with more superficial scarring, whereas T lymphocytes were predominant in subjects with more extensive scarring. Helper T cells outnumbered the cytotoxic T cells in all trachoma biopsies. Cytoplasmic IL-1α and β expression was seen in the conjunctival epithelium in all trachoma specimens. IL-1α and β, TNF-α and platelet-derived growth factor were detected in macrophages infiltrating the substantia propria. Trachoma subjects showed more inflammatory cells compared with controls and the expression of cytokines was absent in normal subjects.
19. 19 Ghaem-Maghami S, Bailey R, Maybey D, Hay P, Mahdi D, Joof H, et al. Characterisation of B cell responses to Chlamydia trachomatis antigens in humans with trachoma. Infect Immun 1997; 65:4958-4964.
20. 20 Yang X, Hayglass K, Brunham R. Different roles are played by alpha beta and gamma delta T cells in acquired immunity to Chlamydia trachomatis pulmonary infection. Immunology 1998; 94:469-475.
21. 21 Yang X, Brunham R. Gene knockout B cell-deficient mice demonstrate that B cells play an important role in the initiation of T cell responses to Chlamydia trachomatis lung infection. J Immunol 1998; 161:1439-1446. Gene knock out B cell-deficient mice were used in this study to show that B cells play an important rule in mounting an immune response against chlamydial infection. B cell-deficient mice failed to produce an antibody response as well as a DTH response. The Th1 and Th2-related cytokines were also deficient after Chlamydia-specific in-vitro re-stimulation of the spleen cells from B cell knockout mice.
22. + cells. Med Microbiol Immunol (Berl) 1998; 187:71-78.
23. 23 Ojcius D, Bravo de Alba Y, Kanellopoulos J, Hawkins R, Kelly K, Rank R, Dautry-Varsat A. Internalisation of Chlamydia by dendritic cells and stimulation of Chlamydia-specific T cells. J Immunol 1998; 160:1297-1303.
24. 24 Su H, Messer R, Whitmire W, Fischer E, Portis J, Caldwell H. Vaccination against chlamydial genital tract infection after immunisation with dendritic cells pulsed ex vivo with non viable Chlamydiae. J Exp Med 1998; 188:809-818.
25. 25 Tseng C, Rank R. Role of NK cells in early host response to chlamydial genital infection. Infect Immun 1998; 66:5867-5875.
26. 26 Williams D, Grubbs B, Pack E, Kelly K, Rank R. Humoral and cellular immunity in secondary infection due to murine Chlamydia trachomatis. Infect Immun 1997; 65:2876-2882.
27. 27 Perry L, Feilzer K, Calswell H. Immunity to Chlamydia trachomatis is mediated by T helper cells through IFN-gamma dependent and independent pathways. J Immunol 1997; 158:3344-3352.
28. 28 Lampe M, Wilson C, Bevan M, Starnbach M. Gamma interferon production by cytotoxic T lymphocytes is required for resolution of Chlamydia trachomatis infection. Infect Immun 1998; 66:5457-5461.
29. 29 Mehtsa S, Miller R, Ramirez J, Summersgill J. Inhibition of Chlamydia pneumoniae replication in HEp-2 cells by interferon-gamma: role of tryptophan catabolism. J Infect Dis 1998; 177:1326-1331.
30. 30 Igetseme J, Ananaba G, Candak D, Lyn D, Black C. Immune control of chlamydial growth in the human epithelial cell line RT4 involves multiple mechanisms that induce nitric oxide induction, tryptophan catabolism and iron deprivation. Microbiol Immunol 1998; 42:617-625.
31. 31 Williams D, Grubbs B, Darville T, Kelly K, Rank R. A role for interleukin-6 in host defence against murine Chlamydia trachomatis infection. Infect Immun 1998; 66:4564-4567. IL-6 knockout mice were used to study the role of this cytokine in murine lung tissue after intranasal infection with C, trachomatis, IL-6 knockout mice had significantly increased levels of chlamydia in the lung tissue and higher mortality rates compared with controls. The cytokine and antibody profile was compatible with a reduced but reversible Th1-like response in these mice. IL-6 therefore seems important in the early response against C. trachomatis infection.
32. 32 Perry L, Feilzer K, Caldwell H. Neither interleukin-6 nor inducible nitric oxide synthase is required for clearance of Chlamydia trachomatis from the murine genital tract epithelium. Infect Immun 1998; 66:1265-1268.
33. 33 Igesteme J, Perry L, Ananaba G, Uriri I, Ojior O, Kumar S, Caldwell H. Chlamydial infection in inducible nitric oxide synthase knockout mice. Infect Immun 1998; 66:1282-1286.
34. 34 Ramsey K, Miranopuri G, Poulsen C, Marthakis N, Braune L, Byrne G. Inducible nitric oxide synthase does not affect resolution of murine chlamydial genital tract infections or eradication of chlamydiae in primary murine cell culture. Infect Immun 1998; 66:835-838.
35. 35 Sowa S, Sowa J, Collier LH, Blyth WA. Trachoma vaccine field trials in The Gambia. J Hyg (Lond) 1969; 67:699-717.
36. 36 Wang SP, Grayston JT, Alexander ER. Trachoma vaccine studies in monkeys. Am J Ophthalmol 1967; 63 (Suppl.):1615-1630.
37. 37 Wang SP, Grayston JT. Pannus with experimental trachoma and inclusion conjunctivitis agent infection of Taiwan monkeys. Am J Ophthalmol 1967; 63 (Suppl.):1133-1145.
38. 38 Darville T, Andrews C, Laffoon K, Shymasani W, Kishen L, Rank R. Mouse strain dependent variation in the course and outcome of chlamydial genital tract infection is associated with differences in host immune response. Infect Immun 1997; 65:3065-3073.
39. 39 Zhang D, Yang X, Berry J, Shen C, McClarty G, Brunham R. DNA vaccination with the major outer membrane protein gene induces acquired immunity to Chlamydia trachomatis (mouse pneumonitis) infection. J Infect Dis 1997; 176:1035-1040.
40. 40 Igetseme J, Uriri I, Kumar S, Ananba G, Ojior O, Momodu I, et al. Route of infection that induces a high intensity of gamma interferon-secreting T cells in the genital tract produces optimal protection against Chlamydia trachomatis infection in mice. Infect Immun 1998; 66:4030-4035. The effect of route of infection with C. trachomatis was studied in BALB/c mice. The cells from these animals were then studied in vitro. The pre-exposed mice were also re-challenged 70 days later. Oral and subcutaneous infection produced the least response, whereas intranasal and intravenous infection produced the highest number of IFN-γ-producing T cells. Compared with intravenous infection, intranasal infection also produced comparable levels of IgA but higher levels of IgG2a in the vaginal secretions. Intranasally infected mice had the best protection on re-challenge.
41. 41 Rasmussen S. Chlamydial immunology. Curr Opin Infect Dis 1998; 11:37-41.